Glycerin

Glycerin

SCHEMBL5364722

CC(=O)[O-].OCC(O)CO.[Li+]

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Glycerin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.53
ALDH1A1 P00352 1/20 0.53
CA1 P00915 2/20 0.47
SLC22A16 Q86VW1 1/20 0.42
THRB P10828 1/20 0.36
CA4 P22748 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
OR51E2 Q9H255 1/20 0.35
KDM4E B2RXH2 1/20 0.32
DUSP3 P51452 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycerin SCHEMBL10693194 0.94 LMNA (0.53) LMNAALDH1A1CA1SLC22A16THRB
Glycerin SCHEMBL29000918 0.94 LMNA (0.53) LMNAALDH1A1CA1SLC22A16THRB
Glycerin SCHEMBL8814162 0.94 LMNA (0.53) LMNAALDH1A1CA1SLC22A16THRB
Glycerin SCHEMBL8814160 0.94 LMNA (0.53) LMNAALDH1A1CA1SLC22A16THRB
Glycerin SCHEMBL15453340 0.94 LMNA (0.53) LMNAALDH1A1CA1SLC22A16THRB
Glycerin SCHEMBL28811950 0.94 LMNA (0.53) LMNAALDH1A1CA1SLC22A16THRB
Glycerin SCHEMBL10693196 0.94 LMNA (0.53) LMNAALDH1A1CA1SLC22A16THRB
Glycerin SCHEMBL967740 0.94 LMNA (0.53) LMNAALDH1A1CA1SLC22A16THRB
Glycerin SCHEMBL27802309 0.94 LMNA (0.53) LMNAALDH1A1CA1SLC22A16THRB
Glycerin SCHEMBL28286835 0.94 LMNA (0.53) LMNAALDH1A1CA1SLC22A16THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7220851-B2 Nucleic acid encoding calcyon, a D-1 like dopamine receptor activity modifying protein MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE, INC. (US) 2007-05-22 US disclosed
EP-1117688-B1 D-1 LIKE DOPAMINE RECEPTOR ACTIVITY MODIFYING PROTEIN MED COLLEGE GEORGIA RES INST (US) 2005-04-27 EP disclosed
US-20030073818-A1 D-1 like dopamine receptor activity modifying protein BERGSON CLARE (US) 2003-04-17 US disclosed
US-6469141-B1 (RAMP) WHICH IS A SINGLE TRANSMEMBRANE PROTEIN, DESIGNATED P24, OR CALCYON, THAT INTERACTS WITH A C-TERMINAL INTRACELLULAR SEGMENT OF THE HD1 DOPAMINE (DA) RECEPTOR, USE IN DRUG SCREENING AND DIAGNOSTICS MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE INC. 2002-10-22 US disclosed
EP-1117688-A1 D-1 LIKE DOPAMINE RECEPTOR ACTIVITY MODIFYING PROTEIN Medical College Of Georgia Research Institute, Inc. (US) 2001-07-25 EP disclosed
WO-2000021997-A1 D-1 LIKE DOPAMINE RECEPTOR ACTIVITY MODIFYING PROTEIN MEDICAL COLLEGE GEORGIA RESEARCH INSTITUTE, INC. (US) 2000-04-20 WO disclosed